Navigation Links
Next-Generation Hemostatic Dressing Available for Military Emergencies

HemCon offers revolutionary, easy to use Z-Folded design with antibacterial effectiveness.

Portland, OR (Vocus) July 21, 2009 -- HemCon Medical Technologies, Inc., today announced the launch of the ChitoGauze™ dressing platform. ChitoGauze is a next generation, z-folded hemostatic chitosan dressing, designed for battlefield and acute care use and is proven effective on severe, arterial bleeding. The initial product design received FDA 510(k) clearance in April 2009 and is available immediately for the military medical market in a 4 inch by 4 yard flexible and conforming gauze dressing.

From the creators of the hemostatic HemCon® Bandages, saving lives on the battlefield since 2003, comes a uniquely formulated chitosan impregnated gauze dressing. Designed to offer the latest in battlefield care requirements, this hemostatic dressing is formed in a unique z-folded pleat making delivery from package to wound easier and quicker than with a rolled product. "The dynamic stresses of combat operations can create an environment that is often overwhelming for battlefield care providers. A product that is not only highly effective, but is also easily employed is paramount. A simple modification such as making your package easy to open, or a z-folded dressing rather than rolled, can save a medic precious time which translates to saving lives," said former U.S. Army Medic Christopher Murphy, now of Wake Forest University. HemCon states that in addition to the z-fold, the dressing will ship by Fall 2009 with a packaging configuration that can be opened from any angle to offer easier, more rapid and sterile deployment. "Over our long and strong relationship with the U.S. Army, HemCon has teamed with military medical professionals to understand the latest field requirements and deliver what is needed. It's our mission to continue to help keep our soldiers coming home. Through the launch of the ChitoGauze platform, we're able to provide a critical, safe dressing that saves lives," said Bill Block, President of HemCon, U.S. and former U.S. Army Ranger.

The unique formulation of hemostatic ChitoGauze also offers antibacterial properties which provide medical professionals a multi-layered solution to help avoid infection. "As a physician, there's a great deal to consider when treating a wound - whether you are on the battlefield or in the ER. Having an antibacterial, protective layer provides an element of defense I want my patients to have," said Sudip Bose, MD, FACEP, FAAEM, attending Emergency Physician and former Major, U.S. Army. In testing, ChitoGauze demonstrated antibacterial properties against a wide range of microorganisms, including MRSA, VRE and Acinetobacter Baumannii.

HemCon's proprietary manufacturing process and the natural, unique characteristics of chitosan together create the ChitoGauze mechanism of action which slows blood movement through the dressing, offering a local hemostatic solution. The chitosan in ChitoGauze, without the addition of pro-clotting agents, binds red blood cells and platelets on the dressing's surface which provides localized clotting, independently from the normal clotting cascade. Localized clotting mitigates risk of emboli formation which can be found through the use of pro-clotting agents2.

About HemCon Medical Technologies Inc.
HemCon Medical Technologies, Inc. is a leading global developer of advanced medical products designed to improve the standard of patient care. The company is responsible for developing the chitosan-based HemCon dressing used by thousands of military and civilian first responders and is changing wound care best practices in hospital, dental and clinical settings. In addition, HemCon is leading the charge to develop and license unique, life-saving medical advances, including Lyophilized Human Plasma and NanospiderTM technologies. HemCon is headquartered in Portland, Ore., with additional commercial operations in Ireland; England; Germany and the Czech Republic. For more information, please visit

1 Data from the ChitoGauze FDA submission is available for review from HemCon Medical Technologies, Inc.
2 Studies conducted by Prof. John Whitelock, University of New South Wales, in conjunction with an Australian ARC Linkage Grant.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Nonin Medical Announces FDA Clearance for its Next-Generation Regional Oximetry System
2. Abbott Receives CE Mark for Companys Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
3. Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
4. Abbott Announces Launch of Next-Generation Embolic Protection System
5. Purity Products Partners with Leading Vitamin D Expert to Create Next-Generation D3 Complex
6. Nonin Medical Introduces Next-Generation Regional Oximeter at Euroanaesthesia 2009
7. First heart patients implanted with next-generation mechanical heart pump
8. SearchAmerica(R) Unveils Next-Generation Red Flags Rule System for Health Care
9. Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections
10. Parata Adopts Smart Service for Next-Generation Solutions
11. InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution
Post Your Comments:
Related Image:
Next-Generation Hemostatic Dressing Available for Military Emergencies
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android ... The new app features a more intuitive SleepScore™ that rates sleep quality on a ... The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving (MADD) ... below 10,000 for the first time since 2011. In 2014, there were 9,967 fatalities ... released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in ...
(Date:11/25/2015)... ... 2015 , ... Privately owned Contract Development and Manufacturing Organization ... current state of the art research, development and manufacturing facility outside of Fort ... capacity as well as to support its clients’ growing research and development and ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
(Date:11/25/2015)... 25, 2015 Kitov Pharma ... KTOV), a biopharmaceutical company focused on the development of ... conditions, today announced the closing of its previously announced ... ADSs ), each representing 20 ordinary shares of the ... The ADSs and warrants were issued in a fixed ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Today AVACEN Medical announced the issue of ... Thermal Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry heat ... Treatment Method. Photo - ... ... ...
Breaking Medicine Technology: